|| Checking for direct PDF access through Ovid
Adherence and obtaining parental con-sent for their children’s participation are key factors in clinical neonatal research influenced by: the quality of the information delivered and the interaction between parents and investigators. This exchange of information is one of the most serious challenges as failure to disclose some important items by clinicians would lead to difficul-ties in decision making by parents, not being an informed consent process anymore. This Delphi survey aims to es-tablish a consensus between parents of preterm infants and healthcare professionals on the information criteria deemed essential by both parties in order to improve the recruitment of newborns in clinical trials.This study has been conducted among par-ents of preterm newborns and healthcare professionals (pediatri Drug use during pregnancy: a systematic re-viewcians, neonatologists, obstetricians; experts in phar-macology, researchers, clinical research studies coordina-tors; ethicists and members of ethics committees). In this 3-phase study, the items were defined by the Scientific Committee (CS), composed of 11 clinicians (from 7 coun-tries: Belgium, Canada, France, Spain, Switzerland, United Kingdom, United States) and 1 European representative of newborn parents associations (European Foundation for the Care of Newborn Infants, EFCNI). Then, the Com-mittee of Experts (CE), composed of 16 clinicians and 16 parents, members of preterm newborns parents associa-tions (with a balanced distribution in 10 countries), evalu-ates these items on two occasions.96 items were selected by the SC, submitted and evaluated by the CE on a scale from 1 to 9 accord-ing to the importance they had for them, based on their personal experience and beliefs. In the first round, 63/96 items were retained (first level of consensus criteria: me-dian score above 7, 65% of responses in the top tertile between 7 and 9-). The second round, in progress, will refine this selection and only items meeting the second level of consensus criteria (median score above 7, 75% of responses in the top tertile -between 7 and 9-) will be conserved for the final consensus.This parental/professional consensus will improve parents’ information and decision-making pro-cess, respecting ethical and quality criteria to include newborns in clinical trials.